Structure and mechanism of human DNA polymerase eta
- PMID: 20577208
- PMCID: PMC2899710
- DOI: 10.1038/nature09196
Structure and mechanism of human DNA polymerase eta
Erratum in
- Nature. 2011 Aug 18;476(7360):360
Abstract
The variant form of the human syndrome xeroderma pigmentosum (XPV) is caused by a deficiency in DNA polymerase eta (Poleta), a DNA polymerase that enables replication through ultraviolet-induced pyrimidine dimers. Here we report high-resolution crystal structures of human Poleta at four consecutive steps during DNA synthesis through cis-syn cyclobutane thymine dimers. Poleta acts like a 'molecular splint' to stabilize damaged DNA in a normal B-form conformation. An enlarged active site accommodates the thymine dimer with excellent stereochemistry for two-metal ion catalysis. Two residues conserved among Poleta orthologues form specific hydrogen bonds with the lesion and the incoming nucleotide to assist translesion synthesis. On the basis of the structures, eight Poleta missense mutations causing XPV can be rationalized as undermining the molecular splint or perturbing the active-site alignment. The structures also provide an insight into the role of Poleta in replicating through D loop and DNA fragile sites.
Figures





Comment in
-
DNA repair: How to accurately bypass damage.Nature. 2010 Jun 24;465(7301):1023-4. doi: 10.1038/4651023a. Nature. 2010. PMID: 20577203 Free PMC article.
References
-
- Brash DE. Sunlight and the onset of skin cancer. Trends Genet. 1997;13:410–414. - PubMed
-
- Masutani C, et al. The XPV (xeroderma pigmentosum variant) gene encodes human DNA polymerase η. Nature. 1999;399:700–704. - PubMed
-
- Johnson RE, Kondratick CM, Prakash S, Prakash L. hRAD30 mutations in the variant form of xeroderma pigmentosum. Science. 1999;285:263–265. - PubMed
-
- Hishida T, Kubota Y, Carr AM, Iwasaki H. RAD6-RAD18-RAD5-pathway-dependent tolerance to chronic low-dose ultraviolet light. Nature. 2009;457:612–615. - PubMed
-
- Chaney SG, Campbell SL, Bassett E, Wu Y. Recognition and processing of cisplatin- and oxaliplatin-DNA adducts. Crit Rev Oncol Hematol. 2005;53:3–11. - PubMed
Publication types
MeSH terms
Substances
Associated data
- Actions
- Actions
- Actions
- Actions
- Actions
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous